IDYA
IDEAYA Biosciences, Inc. Common Stock
stockNASDAQ
ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya's investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ventures (wuxi), novartis institute of biomedical research, and alexandria real estate. the company has assembled a world-class drug discovery team and scientific advisory board (sab) that is represented by a nobel laureate and three members of the national academy of sciences. ideaya is located in south san francisco and la jolla, california.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.22 | 2026-09-28 | -2.32% | -1.705 |
| 1M | 39.86 | 2026-09-04 | -6.33% | 0.983 |
| 3M | 39.37 | 2026-07-06 | -5.17% | 0.542 |
| 6M | 32.34 | 2026-04-06 | +15.45% | 0.842 |
| 1Y | 27.64 | 2025-10-03 | +35.08% | 0.985 |
| 2Y | 29.97 | 2024-10-04 | +24.57% | — |
| 5Y | 26.88 | 2021-10-04 | +38.90% | 1.071 |
IDEAYA Biosciences, Inc. Common Stock (NASDAQ:IDYA) stock price today is $37.34, and today's volume is 579,047. IDYA is down 1.256% today. The 30 day average volume is 827,446. IDYA market cap is $3.60B with 96.49M shares outstanding.